Talecris Biotherapeutics Announces Alberto Martinez, M.D. New CEO; John Hanson New CFO

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Oct. 27, 2005--After a focused and methodical search, Talecris Biotherapeutics has completed its executive leadership team with the appointments of three experienced, highly regarded executives. Alberto Martinez, M.D., has assumed the position of President and Chief Executive Officer; John Hanson has assumed the position of Chief Financial Officer, and Mel Asbury has been named Senior Vice President of Human Resources.
MORE ON THIS TOPIC